drugset / Trial / NCT00000341

Evaluation of Liquid vs. Tablet Buprenorphine - 6

NCT00000341

Phase 2 Completed 1 enrolled National Institute on Drug Abuse (NIDA)
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the steady-state pharmacokinetics and bioavailability of buprenorphine sublingual tablets vs. sublingual solution.

Timeline

Start
1996-08
Primary completion
Completion
2000-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified Other